Jim Simons Theravance Biopharma, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$9.65 - $11.34 $234,002 - $274,983
24,249 Added 15.93%
176,426 $1.98 Million
Q3 2022

Nov 14, 2022
BUY
$8.39 - $10.22 $1.28 Million - $1.56 Million
152,177 New
152,177 $1.54 Million
Q1 2020

May 14, 2020
SELL
$17.84 - $31.21 $303,333 - $530,663
-17,003 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$16.12 - $25.89 $274,088 - $440,207
17,003 New
17,003 $440,000

Others Institutions Holding TBPH

# of Institutions
122
Shares Held
47.3M
Call Options Held
200
Put Options Held
12.8K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $640M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email